Roche, Cipla to bring Casirivimab/Imdevimab Covid-19 drug to India
Roche India said that India’s Central Drugs Standards Control Organisation (CDSCO) has granted an emergency use authorisation (EUA) for the Casirivimab, Imdevimab antibody cocktail for ... Read More
Kalyan Jewellers extends Gold Ownership Certificate initiative
Kalyan Jewellers said that it will extend its Gold Ownership Certificate initiative, which was launched in 2020 during the Covid-19 lockdown. The initiative has been ... Read More
Bajaj Healthcare launches Favijaj tablets for Covid-19 treatment in India
Bajaj Healthcare Limited (BHL) has launched Favijaj tablets, its generic version of Japan-based Fujifilm's antiviral drug favipiravir for the treatment of mild to moderate Covid-19 ... Read More
Natco Pharma gets CDSCO nod for use of Baricitinib in Covid patients
Natco Pharma has secured emergency use approval for Baricitinib from India’s Central Drugs Standard Control Organization (CDSCO) for the treatment of Covid-19. The Indian pharma ... Read More
Bhansali Engineering Polymers opens 100-bed corona care centre in Mumbai
Bhansali Engineering Polymers (BEPL) has opened a 100-bed corona care centre in Mumbai – dubbed Jito Covid Care Centre in which half of the beds ... Read More
Hero MotoCorp April 2021 sales drop to 372,285 units amid Covid-19 crisis
Indian two-wheeler manufacturer Hero MotoCorp said that it had registered sales of 372,285 motorcycles and scooters during April 2021, which include 339,329 motorcycles and 32,956 ... Read More
Wipro partners with Citrix, HPE to expedite remote working solutions
Wipro said that it has joined forces with Citrix Systems and Hewlett Packard Enterprise (HPE) to offer a robust solution for enterprises to expedite remote ... Read More
Cipla partners with MSD to manufacture and distribute Molnupiravir drug to treat Covid-19
Cipla has entered into a non-exclusive licensing agreement with MSD (called Merck in the US and Canada) for the manufacturing and distribution of Molnupiravir (EIDD-2801/MK-4482), ... Read More
CORAT begins COR-101 clinical trial in hospitalized Covid patients
CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. ... Read More
Sewa to ship 400 oxygen concentrators and medical supplies to India
Sewa International has begun its ‘Help India Defeat Covid-19’ campaign and is sending the first shipment of 400 oxygen concentrators to hospitals and other emergency ... Read More